Primary Immunodeficiency Disorders Market By Treatment Type (Immunoglobulin Therapy {Intravenous, Subcutaneous}, Stem Cell/Bone Marrow Transplant, Gene Therapy, Antibiotics and Antifungal Therapy, Other), By Disease Type (Antibody Deficiency Disorders {Common Variable Immunodeficiency, X-Linked Agammaglobulinemia, Selective IgA Deficiency}, Cellular Immunodeficiency Disorders, Complement Deficiencies, Combined Immunodeficiency Disorders), By Diagnostic Type (Genetic Testing, Blood Testing, Flow Cytometry, Other), By End-User (Hospitals, Specialty Clinics, Homecare Settings, Research Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
Published Date: Dec 2024 | Report ID: MI1602 | 230 Pages
Report Coverage:
By Treatment Type
- Immunoglobulin Therapy
- Intravenous
- Subcutaneous
- Stem Cell
- Gene Therapy
- Antibiotics and Antifungal Therapy
- Other
By Disease Type
- Antibody Deficiency Disorders
- Common Variable Immunodeficiency
- X-Linked Agammaglobulinemia
- Selective IgA Deficiency
- Cellular Immunodeficiency Disorders
- Complement Deficiencies
- Combined Immunodeficiency Disorders
By Diagnostic Type
- Genetic Testing
- Blood Testing
- Flow Cytometry
- Other
By End-User
- Hospitals
- Specialty Clinics
- Homecare Settings
- Research Institutions
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
List of Companies:
- CSL Behring
- Takeda Pharmaceuticals
- Grifols S.A.
- Octapharma AG
- Kedrion Biopharma
- Pfizer Inc.
- Sanofi
- Biotest AG
- Orchard Therapeutics
- Bluebird Bio
- Rocket Pharmaceuticals
- Avrobio
- ADMA Biologics
- LFB S.A.
- China Biologic Products Holdings, Inc.
- Bio Products Laboratory
- Prothya BioSolutions
- Horizon Therapeutics
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.